Device / Technology News

RSS

New technology benefits child suffering from severe form of epilepsy

Brittany Brown has watched her daughter, Amaree, 6, struggle with hundreds of seizures every day for the past six years. Yes, hundreds. Every day.

26 Sep 2015

New technique supplies faster resistance results, can benefit patients with blood poisoning

When treating cases of blood poisoning, doctors resort immediately to broad-spectrum antibiotics. The problem is that in many cases the bacteria are resistant to the medicine.

26 Sep 2015

New project aims to develop web-based tool for women considering CPM

Rutgers Cancer Institute of New Jersey surgical oncologist Laurie J. Kirstein, MD, FACS, and Associate Director for Cancer Prevention, Control and Population Science Sharon L. Manne, PhD, have been awarded a $404,089 grant (R21CA187643) from the National Cancer Institute to explore the decision making process women with non-hereditary breast cancer undergo when considering the removal of a healthy breast.

26 Sep 2015

Ignition interlock devices are effective public safety tools that can prevent deaths, say researchers

The National Highway Traffic Safety Administration estimates intoxicated drivers involved in fatal crashes are six times more likely to have a prior DUI conviction than drivers with no alcohol in their system.

26 Sep 2015

Research reveals significant information about the dynamics of bacterial gels

Research by scientists at the University of York has revealed important new information about the dynamics of bacterial gels which could ultimately suggest new ways of helping prevent or better control diseases such as cystic fibrosis.

26 Sep 2015

Scripps becomes first health care provider in San Diego County to implant Evera MRI SureScan ICD System

Scripps Health is the first health care provider in San Diego County to use the only implantable cardioverter defibrillator (ICD) device approved for use with magnetic resonance imaging (MRI) scans.

26 Sep 2015

Creating a new paradigm for management of yeast infections

Yeasts are unicellular microorganisms classified within the Fungi kingdom. They are well known for their use in baking, winemaking and beer brewing fermentation, but some species of yeast are opportunistic pathogens that can cause infections in humans. "Today, yeast infections are poorly understood, difficult to diagnose, and are becoming increasingly frequent and serious, affecting over 300 million people worldwide.

26 Sep 2015

Scientists identify different CRISPR system with potential to advance genetic engineering

A team including the scientist who first harnessed the revolutionary CRISPR-Cas9 system for mammalian genome editing has now identified a different CRISPR system with the potential for even simpler and more precise genome engineering.

26 Sep 2015

Researchers develop new blood test to diagnose coeliac disease

Diagnosis of coeliac disease requires a tissue sample from the small intestine, which can be extremely unpleasant. Researchers at the Faculty of Medicine have developed a blood test which provides a rapid, painless answer.

25 Sep 2015

Novel brain-computer interface technology allows paralyzed man to walk

Novel brain-computer interface technology created by University of California, Irvine researchers has allowed a paraplegic man to walk for a short distance.

25 Sep 2015

Matchmaker Exchange platform launched for uncovering rare disease genes

In a special issue of Human Mutation, a team including investigators at Brigham and Women's Hospital has announced the launch of the Matchmaker Exchange - a way for the rare disease community to share information and find new connections. Matchmaker Exchange connects databases of genetic information and symptoms that physicians and investigators can "match" with a patient's rare disease.

25 Sep 2015

DNA nanostructures provide novel applications in molecular medicine

Researchers from Aalto University have published an article in the recent Trends in Biotechnology journal. The article discusses how DNA molecules can be assembled into tailored and complex nanostructures, and further, how these structures can find uses in therapeutics and bionanotechnological applications.

25 Sep 2015

Researchers develop chip-based instrument for reliable detection of Ebola virus

A team led by researchers at UC Santa Cruz has developed chip-based technology for reliable detection of Ebola virus and other viral pathogens. The system uses direct optical detection of viral molecules and can be integrated into a simple, portable instrument for use in field situations where rapid, accurate detection of Ebola infections is needed to control outbreaks.

25 Sep 2015

Sticky, protein-rich gel improves cardiac function after simulated heart attacks

A sticky, protein-rich gel created by Johns Hopkins researchers appears to help stem cells stay on or in rat hearts and restore their metabolism after transplantation, improving cardiac function after simulated heart attacks, according to results of a new study.

25 Sep 2015

Revolutionary approach to hematology analysis introduced by Diatron at Medica 2015

The Diatron Group, global provider of hematology and clinical chemistry analyzers, will display their new 3-part differential hematology analyzer (60 test /hour throughput) to the laboratory world for the first time in Dusseldorf, Germany, at Medica 2015 on the 16-19 November. This innovative analyzer has been specially designed to provide unique solutions to the many needs of the rapidly evolving worldwide hematology markets.

From Diatron 25 Sep 2015

EKF’s new Altair 240 revealed to UK audience at IBMS 2015

EKF, announces the UK launch of the Altair™ 240 clinical chemistry analyser at the Institute of Biomedical Science Congress 2015 in Birmingham.

From EKF Diagnostics 24 Sep 2015

Cryoport purchases IP rights to Cryoportal operating platform from Klatu

Cryoport, Inc. today announced the purchase of certain intellectual property and intellectual property rights to the Cryoportal operating platform from KLATU Networks, LLC.

24 Sep 2015

Florida Institute finalizes funding agreement with Aviana

The Florida Institute for the Commercialization of Public Research announced today that it has finalized a funding agreement with Aviana Molecular Technologies, an Orlando-based company with technology developed at the University of Central Florida.

24 Sep 2015

BD Life Sciences announces FDA clearance for BD MAX Enteric Parasite Panel

BD Life Sciences, a segment of global medical technology company BD (Becton, Dickinson and Company), today announced the availability of the U.S. Food and Drug Administration cleared BD MAX Enteric Parasite Panel for use on the BD MAX System.

From BD (Becton, Dickinson and Company) 24 Sep 2015

Alimera Sciences announces results from ongoing study on ILUVIEN

Alimera Sciences, Inc., a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced that Alimera Sciences Limited, its European subsidiary based in London, revealed interim six-month data on ILUVIEN (Fluocinolone Acetonide 190 micrograms intravitreal implant in applicator) from the ongoing study referred to as RESPOND, a non-Randomised, open-label, multicenter phase 4 pilot study on the Effect and Safety of ILUVIEN Fluocinolone Acetonide in chronic diabetic macular edema Patients cOnsidered iNsufficiently responsive to available therapies with or without intravitreal corticosteroiD therapy.

24 Sep 2015